BioElectronics Receives Nationwide CBS News Coverage Print E-mail
By BioMedReports.Com   
Monday, 10 August 2009 05:04
FREDERICK, MD--BioElectronics Corp. (OTC: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced that coverage of the Company's message of drug-free pain relief continues to resonate with members of the press and analyst communities resulting in expanding coverage of company. Over the weekend, CBS News broadcasted a nationwide news segment which discussed how ActiPatch™ can be used to treat heel and foot pain.

"The number of press and analyst inquiries we are receiving is impressive," commented Andrew Whelan, CEO at BioElectronics, Corp. "Members of the press and many financial analysts have shown a keen interest in the Tylenol and acetaminophen safety debate and are paying particular attention to drug-free therapies, such as those offered by BioElectronics. Over the next few months our stakeholders should expect to see coverage of the Company continue to accelerate as the FDA takes formal action relative to these issues. We believe we have a revolutionary set of products that will allow us to rewrite pain management and healing over the next few years. It is truly an exciting time for all of us at BioElectronics as we continue our clinical trials and as we prepare additional FDA filings seeking over the counter clearance for our products."

The latest news story can be viewed on the CBS News website at the following link --

http://www.cbsnews.com/video/watch/?id=5227039n&tag=cbsnewsLeadStoriesAreaMain;cbsnewsLeadStoriesHeadlines

Over the past few weeks there have been numerous other news stories and analyst reports on the Company. We have listed a few of these links below:

http://www.youtube.com/watch?v=gDIM8Wkj744

http://smallcapvoice.com/blog/7-31-09-audio-interview-with-carrie-snyder-independant-analyst-for-bioelectronics-corp-otcpk-biel/

http://www.bioelectronicscorp.com/Documents/ind_analyst.pdf

http://www.youtube.com/watch?v=r01tS-TLd1c

http://biomedreports.com/articles/most-popular/2085-bioelectronics-corporation-otcbiel-poised-for-major-revenue-growth.html

http://seekingalpha.com/instablog/424698-m-e-garza/13391-bioelectronics-corporation-otc-biel-poised-for-major-revenue-growth

http://seekingalpha.com/instablog/424698-m-e-garza/13718-closer-look-at-bioelectronics-corporation-otc-biel-continued

http://www.rttnews.com/Content/BreakingNews.aspx?Node=B1&Id=994627%20&Category=Breaking%20News

http://smallcapvoice.com/blog/6-29-09-audio-interview-with-bioelectronics-corporation-otcpk-biel/

About BioElectronics Corporation

BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx™ Devices, HealFast™ Therapy (www.healfasttherapy.com) and the Allay™ family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see http://www.BioElectronicsCorp.com.

Tylenol is a registered trademark of McNeil pharmaceutical, Inc.




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 

Newsletter